New York, New York 10075


Purpose:

A Phase 4, Multicenter, Randomized, Placebo-controlled, Double-blind, Study of the Efficacy and Safety of Apremilast (CC-10004), in Subjects with Moderate Plaque Psoriasis


Criteria:

Inclusion Criteria: - Males or females, ≥ 18 years of age - Able to adhere to the study visit schedule and other protocol requirements. - Diagnosis of chronic plaque psoriasis for at least 6 months prior to signing the informed consent. - Have moderate plaque psoriasis at screening and baseline as defined by - Must be in general good health (except for psoriasis) as judged by the investigator, based - No prior systemic treatments or biologics for the treatment of psoriatic arthritis, psoriasis - Females must have a negative pregnancy test at screening and baseline. Participants must agree to use contraception during the course of the study Exclusion Criteria: - Other than psoriasis, any clinically significant (as determined by the Investigator) major disease that is currently uncontrolled. - Any condition, including the presence of laboratory abnormalities, which would place the subject at unacceptable risk if he/she were to participate in the study. - Pregnant or breast feeding. - Active substance abuse or a history of substance abuse within 6 months prior to signing the informed consent. - Malignancy or history of malignancy - Topical therapy within 2 weeks of starting trial - Use of phototherapy within 4 weeks prior to starting trial - Use of any investigational drug within 4 weeks prior to starting trial - Prolonged sun exposure or use of tanning booths, which may confound the ability to interpret data from the study. - Prior treatment with apremilast.


NCT ID:

NCT02555826


Primary Contact:

Krista Bohnert
Phone: 212 772 7242
Email: kbohnert@sadickdermatology.com


Backup Contact:

Email: sahmed@sadickdermatology.com
Sadath Ahmed
Phone: 212 772 7242


Location Contact:

New York, New York 10075
United States

Krista Bohnert
Phone: 212-772-7242
Email: kbohnert@sadickdermatology.com

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: November 18, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.